The development and implementation of Immune Checkpoint Inhibitors (ICI) in clinical oncology have significantly improved the survival of a subset of cancer patients with metastatic disease previously considered uniformly lethal. However, the low response rates and the low number of patients with du...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!